Bakuchiol Doesn't Replace Retinol. It Protects It.

Retinol has a credibility problem that has nothing to do with whether it works. The molecule is unstable. It degrades on contact with light, air, and heat. By the time most retinol products are opened, applied, and absorbed, a significant portion of the active ingredient has already broken down into compounds that do nothing useful for your skin.

This is the gap between what retinol can do in a controlled study and what it actually delivers from most formulations sitting on a bathroom shelf.

The Instability Problem

Retinol belongs to the retinoid family, a class of vitamin A derivatives with strong evidence for stimulating collagen production, accelerating cell turnover, and regulating pigmentation. The clinical data is robust. The delivery challenge is equally well documented.

Free-form retinol, the type used in most over-the-counter products, is vulnerable to photolysis (breakdown by light), oxidation (breakdown by air exposure), and isomerisation (structural change that renders it inactive). These processes begin the moment the product is manufactured and accelerate each time you open the jar.

The practical consequence: a retinol product that tests well in laboratory conditions may deliver a fraction of its stated concentration by the time it contacts your skin. The active ingredient is degrading in the bottle, on your face, and during the hours it takes to penetrate to the target cells in your dermis.

Dr Alison Jamieson, Cosmetic Physician, has long regarded this as the second major barrier to retinol efficacy. The first, tolerability, is well known. Scaling, redness, and stinging cause most people to abandon retinol within the first month. But instability is the quieter problem. Even those who tolerate retinol well may be getting less from their product than the label suggests.

Bakuchiol as a Molecular Shield

The conversation around bakuchiol has largely centred on whether it can replace retinol. A 2019 clinical trial published in the British Journal of Dermatology showed it matched retinol on wrinkle and pigmentation outcomes with significantly less irritation. That finding is important, but it obscures a second, arguably more useful property.

Bakuchiol stabilises retinol.

Research into the interaction between these two molecules has demonstrated that at a 4:1 ratio of bakuchiol to retinol, bakuchiol completely prevents retinol from degrading through photodecomposition. Not reduces. Prevents. The bakuchiol molecule intercepts the reactive species that would otherwise break retinol apart, acting as a protective shield around the retinol molecule and extending its functional window.

This shifts the framing entirely. Bakuchiol is not a substitute for retinol. It is retinol's most effective partner. The two ingredients are allies, not alternatives.

The Encapsulation Layer

Stabilisation through bakuchiol addresses degradation from light and oxidation. But there is a second delivery problem: retinol's release profile.

Free-form retinol delivers its full dose in a single burst on application. This creates a sharp peak of activity followed by a rapid decline as the molecule breaks down. The peak is what causes irritation. The decline is what limits results.

Micro-encapsulation solves both sides of this equation. By encasing the retinol molecule in a protective shell, encapsulated retinol releases its active load gradually over several hours rather than all at once. This controlled release achieves a 9-fold increase in retinol's functional half-life compared to free-form delivery.

Lower peak concentration means less irritation. Extended release means more total contact time between retinol and the target cells in your dermis. The same amount of active ingredient does substantially more work.

Two Stabilisation Systems Working Together

The Ultimate A Night Cream combines both approaches. The retinol is micro-encapsulated for controlled release. Bakuchiol is present at the precise 4:1 ratio for photostabilisation. Together, these two systems address different failure modes of conventional retinol delivery.

Encapsulation controls the release rate. Bakuchiol prevents degradation during and after release. The retinol that reaches your cells is intact, active, and delivered at a steady concentration over the full overnight period rather than in a single peak that fades within hours.

This is formulation logic, not ingredient stacking. Each component addresses a specific limitation. The bakuchiol also contributes its own anti-inflammatory properties, which further buffer the retinol-induced irritation that the controlled release has already reduced. Three mechanisms, one outcome: more functional retinol reaching the cells that need it, with less of the side effects that cause people to stop using it.

Why This Matters for Your PM Protocol

Retinol's benefits are dose and time dependent. The clinical improvements documented in published trials, wrinkle reduction, pigmentation correction, collagen stimulation, require consistent use over eight to twelve weeks. Most people who quit do so in the first month, before the compound effects emerge.

Every formulation decision in the Night Cream is oriented toward keeping people in the protocol long enough to see results. The bakuchiol ratio, the encapsulation, the rich lipid base of cupuacu butter, shea butter, and avocado oil that prevents overnight dryness: all of it serves compliance.

Within the PM Protocol, the Night Cream is applied as the final step, after cleansing and serum application. Dr Jamieson recommends graduated introduction: twice weekly for the first fortnight, alternate nights for weeks three and four, then nightly. The stabilised formulation makes this transition substantially smoother than conventional retinol products, but respect for the skin's adaptation process still produces the best long-term outcomes.

The Biocinamide Serum, applied in the preceding step, reinforces the skin barrier through ceramide stimulation and postbiotic support. A stronger barrier tolerates active ingredients with less reactivity. The two products function as a system: barrier support followed by stabilised retinol delivery.

The Practical Difference

When your retinol is stable, encapsulated, and buffered by bakuchiol's anti-inflammatory properties, what changes is not just tolerability. It is the proportion of applied retinol that actually performs its intended function.

More active ingredient reaching your cells. Sustained delivery instead of a spike and crash. Less irritation driving early abandonment. The same molecule, working harder because the formulation protects it from degrading before it does its job.

That is the difference between a retinol product and a retinol protocol.